The Agent DCB, from Boston Scientific, was superior to uncoated balloon angioplasty for the treatment of coronary artery in-stent restenosis in a pivotal trial.
The US Food and Drug Administration has approved Boston Scientific's Agent Drug-Coated Balloon , the first coronary DCB for the treatment of coronary in-stent restenosis in patients with-coated balloon catheter that transfers a therapeutic dose of the antiproliferative drug to the vessel wall to help prevent in-stent restenosis reoccurrence.
Conducted at 40 sites in the United States, the trial randomly assigned patients with coronary artery in-stent restenosis to the Agent DCB or to conventional balloon
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Treatment Breakthrough: FDA Approves First Ever Drug For FrostbiteThe Best in Science News and Amazing Breakthroughs
Read more »
FDA Approves Drug to Reduce Accidental Food AllergiesThe new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.
Read more »
FDA approves a drug to treat severe food allergies, including milk, eggs and nutsXolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.
Read more »
FDA Approves First Treatment for Severe FrostbiteThe U.S. Food and Drug Administration (FDA) on Wednesday approved the first treatment for severe frostbite.
Read more »
FDA Approves First Cellular Therapy for Metastatic MelanomaLifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.
Read more »
FDA Approves First Medication For Treating Allergic Reactions To Multiple FoodsI'm a Chicago-based reporter. My previous experiences include work at Chemical Watch, Becker's Healthcare, Chicago Lawyer Magazine and The Kane County Chronicle. I graduated from DePaul University with degrees in journalism and psychology. Email me at cgleesonforbes.com and follow me on Twitter caileygleeson.
Read more »